1. Home
  2. USNA vs GRAL Comparison

USNA vs GRAL Comparison

Compare USNA & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • GRAL
  • Stock Information
  • Founded
  • USNA 1992
  • GRAL 2016
  • Country
  • USNA United States
  • GRAL United States
  • Employees
  • USNA N/A
  • GRAL N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • GRAL
  • Sector
  • USNA Health Care
  • GRAL
  • Exchange
  • USNA Nasdaq
  • GRAL NYSE
  • Market Cap
  • USNA 565.2M
  • GRAL 1.6B
  • IPO Year
  • USNA 1996
  • GRAL N/A
  • Fundamental
  • Price
  • USNA $31.33
  • GRAL $38.72
  • Analyst Decision
  • USNA Hold
  • GRAL Buy
  • Analyst Count
  • USNA 1
  • GRAL 3
  • Target Price
  • USNA $36.00
  • GRAL $31.50
  • AVG Volume (30 Days)
  • USNA 149.1K
  • GRAL 1.3M
  • Earning Date
  • USNA 07-22-2025
  • GRAL 08-12-2025
  • Dividend Yield
  • USNA N/A
  • GRAL N/A
  • EPS Growth
  • USNA N/A
  • GRAL N/A
  • EPS
  • USNA 1.82
  • GRAL N/A
  • Revenue
  • USNA $876,242,000.00
  • GRAL $130,711,000.00
  • Revenue This Year
  • USNA $13.04
  • GRAL $19.52
  • Revenue Next Year
  • USNA $7.36
  • GRAL $20.37
  • P/E Ratio
  • USNA $17.94
  • GRAL N/A
  • Revenue Growth
  • USNA N/A
  • GRAL 30.47
  • 52 Week Low
  • USNA $23.10
  • GRAL $12.33
  • 52 Week High
  • USNA $48.85
  • GRAL $63.99
  • Technical
  • Relative Strength Index (RSI)
  • USNA 49.84
  • GRAL N/A
  • Support Level
  • USNA $32.01
  • GRAL N/A
  • Resistance Level
  • USNA $33.95
  • GRAL N/A
  • Average True Range (ATR)
  • USNA 0.91
  • GRAL 0.00
  • MACD
  • USNA -0.03
  • GRAL 0.00
  • Stochastic Oscillator
  • USNA 27.49
  • GRAL 0.00

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About GRAL GRAIL INC

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Share on Social Networks: